Bioinova

Bioinova is a Czech biotech firm with a dual focus on advanced cell therapies and molecular diagnostics. Originating from the Institute of Experimental Medicine, it leverages its research heritage to develop proprietary stem cell products and rapid diagnostic tests. The company operates under stringent GMP and ISO certifications, supporting both therapeutic development and a commercial tissue banking service. Its integrated model spans from R&D to manufacturing and diagnostics commercialization.

Platform for isolation, expansion, and GMP manufacturing of dental pulp-derived stem cells (DPSCs) for cell therapy, combined with proprietary molecular diagnostic technologies for rapid infection testing.

Bioinova competes in the broad and competitive cell therapy space against large pharma and biotech firms, while its dental pulp banking service faces competition from global cord blood and tissue banks. In diagnostics, it competes with established multinational IVD companies and nimble startups in the rapid testing segment.